haloperidol has been researched along with 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, M; Fuxe, K; Strömberg, I; Terasmaa, A | 1 |
1 other study(ies) available for haloperidol and 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
Article | Year |
---|---|
Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Topics: Analgesics; Animals; Basal Ganglia; Binding, Competitive; Cyclohexanols; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Up-Regulation | 2005 |